On June 8, 2022, Senti Biosciences, Inc. closed the transaction. The company has amended the terms of the transaction and received gross proceeds of $50.6 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 USD | +4.05% | +3.24% | -56.06% |
1st Jan change | Capi. | |
---|---|---|
-56.06% | 14.17M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- SNTI Stock
- News Senti Biosciences, Inc.
- Senti Biosciences, Inc. announced that it has received $50.6 million in funding from a group of investors